The immunopathology of sepsis and potential therapeutic targets.
about
A guiding map for inflammation.Elevated Red Cell Distribution Width as a Prognostic Marker in Severe Sepsis: A Prospective Observational Study.Immunosuppression and herpes viral reactivation in intensive care unit patients: one size does not fit all.Acacetin attenuates mice endotoxin-induced acute lung injury via augmentation of heme oxygenase-1 activity.Sphingosine 1-Phosphate- and C-C Chemokine Receptor 2-Dependent Activation of CD4+ Plasmacytoid Dendritic Cells in the Bone Marrow Contributes to Signs of Sepsis-Induced Immunosuppression.Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock.Interleukin-18: Biological properties and role in disease pathogenesis.Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells.The apelinergic system as an alternative to catecholamines in low-output septic shock.Scutellarin Suppresses NLRP3 Inflammasome Activation in Macrophages and Protects Mice against Bacterial Sepsis.A pro-inflammatory role of Fcα/μR on marginal zone B cells in sepsis.Are histones real pathogenic agents in sepsis?Innate immune responses to trauma.Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.Recent advances in nanomedicine for sepsis treatment.Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury via Suppressing Nuclear Pyruvate Kinase M2-Signal Transducer and Activator of Transcription 3 Pathway.Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics.Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Extracellular Vesicles as Markers and Mediators in Sepsis.The immunosuppressive face of sepsis early on intensive care unit-A large-scale microarray meta-analysis.Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected.Early application of continuous high-volume haemofiltration can reduce sepsis and improve the prognosis of patients with severe burns.Arguing for Adaptive Clinical Trials in Sepsis.The Emperor Has No Clothes? Searching for Dysregulation in SepsisKlebsiella pneumoniae infection of murine neutrophils impairs their efferocytic clearance by modulating cell death machineryLINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agentEpidemiology and Immune Pathogenesis of Viral SepsisPersistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgeryImmune Functional Assays, From Custom to Standardized Tests for Precision MedicineImpact of human sepsis on CCCTC-binding factor associated monocyte transcriptional response of Major Histocompatibility Complex II componentsTherapeutic Potential of the Gut Microbiota in the Prevention and Treatment of SepsisClinical-grade mesenchymal stem cells derived from umbilical cord improve septic shock in pigs
P2860
Q40128384-7FFB366A-0A1E-4A50-8ECC-FA99667E67BFQ42212854-44C25B85-254B-422D-9153-7F66AED1B54AQ42350944-EDBFE985-BDBA-4F0C-AF7F-2A2180C9A5A4Q46291808-F69E4183-B3E1-46C8-9B95-C49DBF54D3ABQ47095059-B9891A0F-8BA0-4712-821B-9BC66415A630Q47153305-4880AA7B-E58B-4593-A381-C026D2D6873FQ47285927-E44660BA-AAB8-4032-B196-E7DEF3B58435Q47354821-C7081B35-7BFC-477A-B54F-D71864C17360Q47653604-7AAB81E3-B7A6-478F-A1B1-389A6DAF59CDQ49195429-B9F02D90-F393-4EFB-87DD-8E306C95233EQ49557768-E1843922-9D9E-4F95-ABE8-3CEDD00403A2Q50158679-33C46A27-C02B-426C-B76B-5C4EB5A9A5E4Q52366499-97C031B3-72D7-4731-8927-CCB91586B022Q52585071-27825C0A-960E-4D4B-9558-3492744D62E0Q52668621-59979173-1F63-4E0D-8F56-CB46EDD21945Q54222088-4324B776-BF60-4A21-A41E-2B5251088601Q54933489-69008D87-B6C1-4949-B3C1-34D1AEEFEA5FQ54967965-9DBBCB63-255F-4408-BF94-1D3DC4D38C56Q55044603-EA27F94F-3BB1-44C5-8974-D0EFE2C4F2E9Q55254635-065DF250-E7C7-4604-BE34-3793F5D7A3A8Q55280312-3EF5A30B-4302-4135-8872-521328436D66Q55312246-CFBC3A62-3782-4861-A48B-8A76B1179373Q55510371-8C9E6358-75BF-44C1-AC6E-DE1FDC49F474Q55691752-98A6E7C1-C16C-48B2-9B73-E1CD63012512Q56888659-F008B694-8459-4643-9092-FC86B52E491AQ57061909-53B5479F-1B10-4A0A-B7CD-4F743F3924EEQ57296199-23E6AC0D-8E29-463C-A92C-5CFF7956B92CQ57490857-FED72DAD-0470-4405-8E39-59FF91D26057Q58072342-AB32C234-EE79-46E2-8690-C8E7B2938219Q58553789-5E0A952E-13A9-4AE4-8CC6-30029D6DE665Q58744056-E1196020-88E9-4401-AB1D-BF5B96C2B04BQ58754447-5A535B85-9582-40F4-B4E7-B38E79787660Q58796084-812F0BED-A708-43F4-B8D9-05E2B50C6C1E
P2860
The immunopathology of sepsis and potential therapeutic targets.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The immunopathology of sepsis and potential therapeutic targets.
@ast
The immunopathology of sepsis and potential therapeutic targets.
@en
type
label
The immunopathology of sepsis and potential therapeutic targets.
@ast
The immunopathology of sepsis and potential therapeutic targets.
@en
prefLabel
The immunopathology of sepsis and potential therapeutic targets.
@ast
The immunopathology of sepsis and potential therapeutic targets.
@en
P2093
P356
P1476
The immunopathology of sepsis and potential therapeutic targets.
@en
P2093
Brendon P Scicluna
Frank L van de Veerdonk
Mihai G Netea
P2888
P356
10.1038/NRI.2017.36
P577
2017-04-24T00:00:00Z
P6179
1085050466